GeoPharma, Inc. Key Financial Ratios and Statistics
Financial Ratios and Key Statistics FYE 31-Mar
| Profitability | 2008 | Leverage | 2008 |
| Net Inc/Comm Equity | -0.11 | Total Liab/Total Assets | 0.54 |
| Net Inc/Total Assets | -0.10 | Total Liab/Inv Cap | 1.05 |
| Net Inc/Inv Cap | -0.20 | Total Liab/Comm Equity | 0.60 |
| Pretax Inc/Net Sales | -0.19 | Interest Coverage Ratio | -16.15 |
| Net Inc/Net Sales | -0.13 | Curr Debt/Equity | 0.17 |
| Cash Flow/Net Sales | -0.03 | LTD/Equity | 0.34 |
| SG&A/NetSales | 0.34 | Total Debt/Equity | 0.51 |
| Asset Utilization | Liquidity | ||
| Net Receivables Turnover | 6.24 | Quick Ratio | 0.56 |
| Inventory Turnover | 4.20 | Current Ratio | 1.05 |
| Inventory Day Sales | 0.01 | Net Rec/Curr Assets | 0.29 |
| Net Sales/Work Cap | 41.63 | Inv/Curr Assets | 0.46 |
| Net Sales/PP&E | 4.02 |
GeoPharma, Inc. Key Financial Ratios and Statistics